# InStride Health

> InStride Health is a Boston-based virtual specialty clinic that treats anxiety and OCD in kids, teens, and young adults ages 7 to 24. Founded by Harvard-trained clinicians from McLean Hospital, it delivers insurance-covered, evidence-based care - cognitive behavioral therapy with exposure and response prevention - through a dedicated three-person care team that coaches patients in the real-world settings where their anxiety actually shows up: school, home, the dinner table. The company has raised $56 million and operates across the Northeast.

- **Founded:** 2021
- **Headquarters:** Boston, Massachusetts, United States
- **Founders:** Mona Potter (Co-Founder & Chief Medical Officer), Kathryn Boger (Co-Founder & Chief Clinical Officer), John Voith (Co-Founder & CEO), James McElhiney (Co-Founder & CTO)
- **Team size:** ~180 employees
- **Products:** Virtual specialty outpatient treatment, Exposure and Response Prevention (ERP) coaching, Medication management, Caregiver and family support
- **Notable:** Raised $56M total including an oversubscribed $30M Series B led by General Catalyst (March 2024), 97% of graduates experience clinical improvement, 98% of caregivers would recommend InStride

## Products & services

- **Virtual specialty outpatient treatment** — Insurance-covered care for pediatric and young-adult anxiety and OCD, delivered through text, phone, and video by a dedicated three-person care team (therapist, exposure coach, and psychiatrist).
- **Exposure and Response Prevention (ERP) coaching** — Real-world, real-time exposure therapy coaching delivered where symptoms occur - at home, school, restaurants, and in the community - rather than only in an office.
- **Medication management** — In-program psychiatric medication management with no external referral required.
- **Caregiver and family support** — Family involvement, caregiver support groups, and care coordination with schools and referring providers built into the treatment model.

## Achievements

- Raised $56M total including an oversubscribed $30M Series B led by General Catalyst (March 2024)
- 97% of graduates experience clinical improvement
- 98% of caregivers would recommend InStride
- 81% of caregivers report reduced caregiver strain
- Under 1% hospitalization rate in the year following program completion
- Built on and scaling the evidence-based McLean Anxiety Mastery Program
- Expanded to seven Northeast states since 2022 launch

## Latest updates

- **2024-03** — Closed an oversubscribed $30M Series B led by General Catalyst to expand into new markets and invest in clinical quality, bringing total funding to $56M.
- **2022-10** — Formally launched with $26M and support from McLean Hospital and Mass General Brigham to scale virtual pediatric anxiety and OCD care.

## Links

- Website: https://instride.health
- LinkedIn: https://www.linkedin.com/company/instride-health
- Twitter/X: https://twitter.com/InStrideHealth
- Instagram: https://www.instagram.com/instride.health/
- Facebook: https://www.facebook.com/Instride.Health

---

Profile page: https://yespress.io/instride-health
Published by YesPress — https://yespress.io
Last updated: 2026-06-07